Nuveen Asset Management’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $12.4M | Sell |
465,526
-77,067
| -14% | -$2.05M | ﹤0.01% | 1483 |
|
|
2024
Q3 | $15.5M | Buy |
542,593
+256,082
| +89% | +$7.3M | ﹤0.01% | 1349 |
|
|
2024
Q2 | $6.24M | Buy |
286,511
+96,883
| +51% | +$2.11M | ﹤0.01% | 1839 |
|
|
2024
Q1 | $4.2M | Buy |
189,628
+7,154
| +4% | +$158K | ﹤0.01% | 2078 |
|
|
2023
Q4 | $3.94M | Buy |
182,474
+6,190
| +4% | +$134K | ﹤0.01% | 2095 |
|
|
2023
Q3 | $2.98M | Sell |
176,284
-240,130
| -58% | -$4.06M | ﹤0.01% | 2127 |
|
|
2023
Q2 | $5.71M | Buy |
416,414
+10,656
| +3% | +$146K | ﹤0.01% | 1834 |
|
|
2023
Q1 | $9.22M | Buy |
405,758
+103,109
| +34% | +$2.34M | ﹤0.01% | 1535 |
|
|
2022
Q4 | $7.12M | Buy |
302,649
+191,974
| +173% | +$4.52M | ﹤0.01% | 1709 |
|
|
2022
Q3 | $2.89M | Sell |
110,675
-1,980
| -2% | -$51.6K | ﹤0.01% | 2196 |
|
|
2022
Q2 | $2.47M | Buy |
112,655
+40,888
| +57% | +$898K | ﹤0.01% | 2330 |
|
|
2022
Q1 | $3.13M | Buy |
71,767
+776
| +1% | +$33.9K | ﹤0.01% | 2294 |
|
|
2021
Q4 | $2.76M | Sell |
70,991
-5,521
| -7% | -$214K | ﹤0.01% | 2405 |
|
|
2021
Q3 | $5.92M | Sell |
76,512
-5,474
| -7% | -$423K | ﹤0.01% | 2115 |
|
|
2021
Q2 | $6.01M | Buy |
81,986
+30,342
| +59% | +$2.22M | ﹤0.01% | 2150 |
|
|
2021
Q1 | $3.54M | Sell |
51,644
-29,149
| -36% | -$2M | ﹤0.01% | 2339 |
|
|
2020
Q4 | $5.43M | Sell |
80,793
-3,509
| -4% | -$236K | ﹤0.01% | 2030 |
|
|
2020
Q3 | $4.34M | Buy |
84,302
+29,462
| +54% | +$1.52M | ﹤0.01% | 1990 |
|
|
2020
Q2 | $2.07M | Sell |
54,840
-9,625
| -15% | -$363K | ﹤0.01% | 2328 |
|
|
2020
Q1 | $1.92M | Sell |
64,465
-50,272
| -44% | -$1.5M | ﹤0.01% | 2211 |
|
|
2019
Q4 | $3.94M | Sell |
114,737
-50,569
| -31% | -$1.74M | ﹤0.01% | 2114 |
|
|
2019
Q3 | $2.99M | Buy |
+165,306
| New | +$2.99M | ﹤0.01% | 2213 |
|